Target intelligence / Profile preview

Human antigen R mRNA 3'-untranslated region (HuR mRNA 3'-UTR)

Target
HuR mRNA 3'-UTR
Molecular classification
RNA, Regulatory RNA element, AU-rich element (ARE)
01

Overview

The Human antigen R (HuR) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the ELAVL1 transcript that governs the stability and translation of the HuR protein. HuR is a ubiquitously expressed RNA-binding protein that stabilizes various mRNAs encoding pro-survival, pro-proliferative, and pro-angiogenic factors by binding to AU-rich elements (AREs). Interestingly, the HuR mRNA 3'-UTR itself contains multiple AREs, allowing the HuR protein to bind to its own transcript in a positive feedback loop that enhances its own expression (Dai et al., 2005). In many cancers, this regulatory mechanism is hijacked, leading to HuR overexpression and the subsequent stabilization of oncogenic mRNAs (Wang et al., 2013). Therapeutic strategies targeting this region include antisense oligonucleotides (ASOs) and siRNAs designed to induce mRNA degradation or block the binding of stabilizing proteins and microRNAs like miR-519 (Abdelmohsen et al., 2008). Disrupting the HuR mRNA 3'-UTR interaction network represents a promising approach to downregulate HuR levels and suppress the expression of multiple downstream oncogenic drivers simultaneously, though systemic toxicity remains a significant concern due to HuR's essential role in normal cellular homeostasis and immune regulation (Srikantan & Gorospe, 2012).

Other names
ELAVL1 mRNA 3'-UTR3'-UTR of ELAVL1HuR 3'-UTRELAVL1 3'-untranslated region
02

Mechanism of action

Antisense-mediated mRNA degradation or translational repression by targeting the 3'-untranslated region to disrupt the HuR autoregulatory loop and reduce protein expression.

03

Biological functions

Post-transcriptional regulationmRNA stabilityAutoregulationTranslation regulation
04

Disease associations

CancerInflammationNeurodegenerative disease
05

Safety considerations

Systemic toxicity due to HuR's role in normal homeostasisOff-target effects of RNA-based therapeuticsPotential for widespread disruption of mRNA stability in healthy cells
06

Interacting drugs

siHuR

3 more in the full profile.

07

Biomarkers

HuR protein expressionHuR mRNA levelsVEGF expressionCOX-2 expression

Beyond the preview

Go deeper on Human antigen R mRNA 3'-untranslated region (HuR mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human antigen R mRNA 3'-untranslated region (HuR mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call